- Home
- KBR vs BIRK Comparison
KBR vs BIRK Comparison
Compare KBR & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KBR | BIRK |
|---|---|---|
| Founded | 1901 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.6B |
| IPO Year | 2006 | 2023 |
Fundamental Metrics
Financial Performance| Metric | KBR | BIRK |
|---|---|---|
| Price | $37.32 | $30.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 14 |
| Target Price | $52.43 | ★ $61.43 |
| AVG Volume (30 Days) | 987.8K | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.83% | N/A |
| EPS Growth | ★ 15.05 | N/A |
| EPS | ★ 1.55 | N/A |
| Revenue | ★ $5,767,000,000.00 | N/A |
| Revenue This Year | $4.56 | $13.71 |
| Revenue Next Year | $5.11 | $14.30 |
| P/E Ratio | $23.61 | ★ $17.48 |
| Revenue Growth | ★ 2.27 | N/A |
| 52 Week Low | $29.94 | $30.25 |
| 52 Week High | $52.23 | $50.73 |
Technical Indicators
Market Signals| Indicator | KBR | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 28.97 |
| Support Level | $35.91 | N/A |
| Resistance Level | $38.45 | $37.29 |
| Average True Range (ATR) | 0.87 | 1.18 |
| MACD | -0.18 | -0.24 |
| Stochastic Oscillator | 36.97 | 6.08 |
Price Performance
Historical ComparisonAbout KBR KBR Inc.
KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 36,000 people. The firm generated $7.8 billion in revenue in 2025.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.